BLACK CYBER WEEK! Publikacje i multimedia nawet do 80% taniej i darmowa dostawa od 350 zł! Sprawdź >
OBS jest rosnącym problemem zdrowotnym, związanym z licznymi powikłaniami metabolicznymi oraz schorzeniami kardiologicznymi. Rozpoznanie bezdechu zawsze powinno skłaniać lekarza do całościowej oceny pacjenta pod kątem możliwych chorób współistniejących i powikłań narządowych. Ogromny udział w diagnostyce i leczeniu tej grupy chorych mają lekarze kardiolodzy.
ABSTRACT
Does a patient with obstructive sleep apnea require cardiac consultation?
Obstructive sleep apnea (OSA) is characterized by recurrent episodes of partial (hypopnea) or complete (apnea) airway closure during sleep due to upper airway collapse, followed by hypoxia and sympathetic activation. A majority of studies show a strong correlation between obstructive sleep apnea and cardiovascular diseases, including coronary artery disease, hypertension, arrhythmia and heart failure. Continuous positive airway pressure, the first-line treatment for OSA, is highly effective in relieving symptoms and improving the quality of life, but has a limited effect on reducing cardiovascular risk. The purpose of this paper is to find out if patients diagnosed with OSA require cardiovascular screening.
Piśmiennictwo
1. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015 Apr;3(4):310-8
2. Tietjens JR, Claman D, Kezirian EJ, et al. Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc 2019;8:e010440
3. Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 2017;69(7):841-58
4. Ashrafian H, Toma T, Rowland SP, et al. Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg 2015;25(7):1239-50
5. Meslier N, Gagnadoux F, Giraud P, et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003;22(1):156-60
6. Linz D, McEvoy RD, Cowie MR, et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment A Review. JAMA Cardiol 2018;3(6):532-40
7. Arzt M, Young T, Finn L, et al. Bradley Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172:1447-51
8. Li X, Zhou X, Xu X, et al. Effects of continuous positive airway pressure treatment in obstructive sleep apnea patients with atrial fibrillation: A meta-analysis. Medicine 2021;100:15(e25438)
9. Hindricks G, Potpara T, Dagres N, et al. Wytyczne ESC 2020 dotyczące diagnostyki i leczenia migotania przedsionków opracowane we współpracy z European Association of Cardio-Thoracic Surgery (EACTS). Zeszyty Edukacyjne – Kardiol Pol 2021;2:1-137
10. Garrigue S, Pépin JL, Defaye P, et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007 Apr 3;115(13):1703-9
11. Pearse SG, Cowie MR. Sleep-disordered breathing in heart failure. Eur J Heart Fail 2016 Apr;18(4):353-61
12. Khattak HK, Hayat F, Pamboukian SV, et al. Obstructive Sleep Apnea in Heart Failure: Review of Prevalence, Treatment with Continuous Positive Airway Pressure, and Prognosis. Tex Heart Inst J 2018 Jun 1;45(3):151-61
13. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021 Sep 21;42(36):3599-726
14. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017 Mar 15;13(3):479-504